XML 53 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCKHOLDERS' DEFICIT (Tables)
 12 Months Ended
Dec. 31, 2018
Equity [Abstract]  
Schedule of Changes in Shareholders' Deficit
The following table shows the changes in stockholders' deficit attributable to the Company and the noncontrolling interests of subsidiaries in which the Company has a majority, but not total, ownership interest:
(In thousands)
The Company
 
Noncontrolling
Interests
 
Consolidated
Balances as of January 1, 2018
$
(11,385,535
)
 
$
41,191

 
$
(11,344,344
)
Net loss
(201,910
)
 
(729
)
 
(202,639
)
Dividends and other payments to noncontrolling interests
—

 
(8,742
)
 
(8,742
)
Share-based compensation
2,066

 
8,517

 
10,583

Foreign currency translation adjustments
(7,161
)
 
(8,763
)
 
(15,924
)
Other adjustments to comprehensive loss
(1,250
)
 
(248
)
 
(1,498
)
Reclassifications adjustments
2,664

 
298

 
2,962

Other, net
(84
)
 
(656
)
 
(740
)
Balances as of December 31, 2018
$
(11,591,210
)
 
$
30,868

 
$
(11,560,342
)
(In thousands)
The Company
 
Noncontrolling
Interests
 
Consolidated
Balances as of January 1, 2017
$
(11,030,835
)
 
$
128,974

 
$
(10,901,861
)
Net loss
(398,060
)
 
(60,651
)
 
(458,711
)
Dividends and other payments to noncontrolling interests
—

 
(46,151
)
 
(46,151
)
Purchase of additional noncontrolling interests
(524
)
 
(703
)
 
(1,227
)
Disposal of noncontrolling interests
—

 
(2,439
)
 
(2,439
)
Share-based compensation
2,488

 
9,590

 
12,078

Foreign currency translation adjustments
31,244

 
12,607

 
43,851

Unrealized holding loss on marketable securities
(370
)
 
(44
)
 
(414
)
Other adjustments to comprehensive loss
6,013

 
707

 
6,720

Reclassifications adjustments
4,864

 
577

 
5,441

Other, net
(355
)
 
(1,276
)
 
(1,631
)
Balances as of December 31, 2017
$
(11,385,535
)
 
$
41,191

 
$
(11,344,344
)
The following table discloses the increase (decrease) in other comprehensive income (loss) related to deferred income tax liabilities for the years ended December 31, 2018, 2017 and 2016, respectively:
(In thousands)
Years Ended December 31,
 
2018
 
2017
 
2016
Pension adjustments and other
$
730

 
$
(314
)
 
$
(1,044
)
Total (increase) decrease in deferred tax liabilities
$
730

 
$
(314
)
 
$
(1,044
)
Schedule of Stock Options Outstanding and Stock Option Activity
The following table presents a summary of CCOH’s stock options outstanding at and stock option activity during the year ended December 31, 2018:
(In thousands, except per share data)
Options
 
Price(3)
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Outstanding, January 1, 2018
4,110

 
$
6.10

 
4.1 years
 
$
2,378

Granted (1)
1

 
5.10

 
 
 
 
Exercised (2)
(31
)
 
2.37

 
 
 
 
Forfeited
(26
)
 
6.56

 
 
 
 
Expired
(809
)
 
10.73

 
 
 
 
Outstanding, December 31, 2018
3,245

 
4.97

 
3.8 years
 
$
2,938

Exercisable
2,822

 
5.10

 
3.4 years
 
$
2,915

Expected to vest
423

 
4.15

 
6.6 years
 
$
23

(1)
The weighted average grant date fair value of CCOH options granted during the years ended December 31, 2018, 2017 and 2016 was $2.39, $2.04 and $2.82 per share, respectively.
(2)
Cash received from option exercises during the years ended December 31, 2018, 2017 and 2016 was $0.1 million, $0.2 million and $0.6 million, respectively.  The total intrinsic value of the options exercised during the years ended December 31, 2018, 2017 and 2016 was $0.1 million, $0.2 million and $0.4 million, respectively.
(3)
Reflects the weighted average exercise price per share.
The following table presents a summary of the Company's stock options outstanding at and stock option activity during the year ended December 31, 2018 ("Price" reflects the weighted average exercise price per share):
(In thousands, except per share data)
Options
 
Price
 
Weighted
Average
Remaining
Contractual Term
Outstanding, January 1, 2018
2,092

 
$
35.09

 
2.6 years
Granted
—

 


 
 
Exercised
—

 


 
 
Forfeited
(529
)
 
35.60

 
 
Expired
(872
)
 
35.88

 
 
Outstanding, December 31, 2017 (1)
691

 
33.70

 
2.8 years
Exercisable
677

 
33.47

 
2.8 years
Expected to Vest
14

 
44.87

 
2.1 years
(1)
Non-cash compensation expense has not been recorded with respect to 0.1 million shares as the vesting of these options is subject to performance conditions that have not yet been determined probable to meet.
Summary of Unvested Options and Changes
A summary of the Company's unvested options and changes during the year ended December 31, 2018 is presented below:
(In thousands, except per share data)
Options
 
Weighted Average Grant Date Fair Value
Unvested, January 1, 2018
543

 
$
19.61

Granted
—

 


Vested (1)
—

 


Forfeited
(529
)
 
18.94

Unvested, December 31, 2018
14

 
44.87

(1)
The total fair value of the options vested during the years ended December 31, 2018, 2017 and 2016 was $0.0 million, $0.0 million and $0.2 million, respectively.
A summary of CCOH’s unvested options at and changes during the year ended December 31, 2018 is presented below:
(In thousands, except per share data)
Options
 
Weighted Average Grant Date Fair Value
Unvested, January 1, 2018
718

 
$
4.19

Granted
1

 
2.39

Vested (1)
(274
)
 
4.28

Forfeited
(22
)
 
3.90

Unvested, December 31, 2018
423

 
4.15

(1)
The total fair value of CCOH options vested during the years ended December 31, 2018, 2017 and 2016 was $1.2 million, $1.6 million and $2.7 million, respectively.
Summary of Restricted Stock Outstanding and Restricted Stock Activity
The following table presents a summary of the Company's restricted stock outstanding and restricted stock activity as of and during the year ended December 31, 2018 (“Price” reflects the weighted average share price at the date of grant):
(In thousands, except per share data)
Awards
 
Price
Outstanding, January 1, 2018
6,219

 
$
3.81

Granted
70

 
0.52

Vested (restriction lapsed)
(627
)
 
4.26

Forfeited
(403
)
 
3.39

Outstanding, December 31, 2018
5,259

 
3.74

The following table presents a summary of CCOH’s restricted stock and restricted stock units outstanding at and activity during the year ended December 31, 2018 ("Price" reflects the weighted average share price at the date of grant):
(In thousands, except per share data)
Awards
 
Price
Outstanding, January 1, 2018
3,900

 
$
5.61

Granted
2,054

 
5.37

Vested (restriction lapsed)
(592
)
 
8.09

Forfeited
(229
)
 
5.64

Outstanding, December 31, 2018
5,133

 
5.23
Schedule of Assumptions Used to Calculate Fair Value of Options
The following assumptions were used to calculate the fair value of CCOH’s options on the date of grant:
 
Years Ended December 31,
 
2018
 
2017
 
2016
Expected volatility
44%
 
42%
 
42% – 44%
Expected life in years
6.3
 
6.3
 
6.3
Risk-free interest rate
2.76%
 
2.12%
 
1.12% – 1.41%
Dividend yield
—%
 
—%
 
—%
Schedule of Loss Per Share
The following table presents the computation of loss per share for the years ended December 31, 2018, 2017 and 2016:
(In thousands, except per share data)
Years Ended December 31,
 
2018
 
2017
 
2016
NUMERATOR:
 
 
 
 
 
Net loss attributable to the Company – common shares
$
(201,910
)
 
$
(398,060
)
 
$
(302,056
)
 
 
 
 
 
 
DENOMINATOR:
 
 
 
 
 
Weighted average common shares outstanding – basic
85,412

 
84,967

 
84,569

Stock options and restricted stock(1):
—

 
—

 
—

Weighted average common shares outstanding – diluted
85,412

 
84,967

 
84,569

 
 
 
 
 
 
Net loss attributable to the Company per common share:
 
 
 
 
 
Basic
$
(2.36
)
 
$
(4.68
)
 
$
(3.57
)
Diluted
$
(2.36
)
 
$
(4.68
)
 
$
(3.57
)
(1)
Outstanding stock options and restricted shares of 7.2 million, 8.3 million and 7.9 million for the years ended December 31, 2018, 2017 and 2016, respectively, were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive.